Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer
Open Access
- 2 December 2008
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 99 (12), 2054-2064
- https://doi.org/10.1038/sj.bjc.6604804
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-κB Transcription and Evasion of ApoptosisJournal of Pharmacology and Experimental Therapeutics, 2008
- Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer RecurrenceClinical Cancer Research, 2008
- Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activationCarcinogenesis: Integrative Cancer Research, 2008
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell GrowthJNCI Journal of the National Cancer Institute, 2008
- Efficacy of low‐dose dexamethasone in castration‐refractory prostate cancerBJU International, 2007
- Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1The Journal of Experimental Medicine, 2006
- Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer CellsClinical Cancer Research, 2006
- Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimensInternational Journal of Gynecologic Cancer, 2005
- Expression of interleukin‐8 gene in radical prostatectomy specimens is associated with advanced pathologic stageThe Prostate, 2005
- Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate CancerClinical Cancer Research, 2004